mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |